Read More Pharma Industry News Moleculin Biotech moves forward with pivotal Annamycin trial in AML after FDA backing Moleculin Biotech, Inc. (Nasdaq: MBRX), a late-stage pharmaceutical company focused on developing innovative treatments for acute myeloid leukemia,… byPallavi MadhirajuFebruary 13, 2025